{"id":1007285,"date":"2026-09-30T17:36:11","date_gmt":"2026-09-30T21:36:11","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-announces-resignation-of-lionel-carnot-from-board-of-directors\/"},"modified":"2026-09-30T17:36:11","modified_gmt":"2026-09-30T21:36:11","slug":"oculis-announces-resignation-of-lionel-carnot-from-board-of-directors","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-announces-resignation-of-lionel-carnot-from-board-of-directors\/","title":{"rendered":"Oculis Announces Resignation of Lionel Carnot from Board of Directors"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"center\">\n        <b>Oculis Announces Resignation of Lionel Carnot from Board of Directors<\/b>\n      <\/p>\n<p align=\"justify\">ZUG, Switzerland, September 30, 2026 &#8212; Oculis Holding AG (Nasdaq: OCS \/ XICE: OCS) (\u201cOculis\u201d or the \u201cCompany\u201d), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in neuro-ophthalmology and ophthalmology, today announces that director Lionel Carnot will be resigning from the Board of Directors, effective today, after nearly a decade of dedicated service since 2017.<\/p>\n<p align=\"justify\">\n        <b>Anthony Rosenberg, Chair of the Board, remarked: <\/b>\u201cOn behalf of the Board and the entire Oculis team, we wish to extend our sincere gratitude to Lionel for his invaluable service, leadership and guidance over nearly a decade, covering a transformative period for Oculis, where it evolved from a private startup company to a publicly listed late-stage biopharmaceutical company. His contributions to the Board and Oculis have been instrumental in our growth and evolution to become an emerging leader in neuro-ophthalmology.\u201d<\/p>\n<p align=\"justify\">\n        <b>Lionel Carnot remarked:<\/b> \u201cIt has been a privilege to work alongside Oculis\u2019 talented and dedicated team committed to addressing significant unmet medical needs and advance innovative solutions for patients suffering from ophthalmic and neuro-ophthalmic diseases. As the Company enters its next stage of growth, this is a timely point for me to step down and focus on other commitments. As an investor, I remain confident in the potential of Oculis\u2019 pipeline and look forward to the Company achieving important milestones in the years ahead.\u201d<\/p>\n<p align=\"justify\">Mr. Carnot\u2019s departure is purely a personal decision and is not the result of any disagreement with the Company on any matter relating to its operations, policies, or practices. Following the resignation, the Board will consist of eight members and the Remuneration Committee, of which Mr. Lionel served as chair, will consist of Geraldine O\u2019Keeffe as chair and Gregory Perry and Robert Warner as members. Pursuant to Swiss law, the vacancy on the Board resulting from Mr. Carnot\u2019s resignation may only be filled at a future annual or special general meeting. Oculis will begin\u00a0identifying a successor for Mr. Carnot and will provide updates as appropriate.<\/p>\n<p align=\"center\">\n        <b>-ENDS-<\/b>\n      <\/p>\n<p>\n        <b>About Oculis<\/b>\n      <\/p>\n<p align=\"justify\">Oculis is a global biopharmaceutical company (Nasdaq: OCS; XICE: OCS) focused on breakthrough innovations to address significant unmet medical needs in neuro-ophthalmology. Oculis\u2019 highly differentiated late-stage clinical pipeline focuses on two core product candidates. Privosegtor is a breakthrough neuroprotective candidate in the PIONEER program, which consists of studies intended to support registration plans for treatment of optic neuropathies, including optic neuritis (ON) and non-arteritic anterior ischemic optic neuropathy (NAION). Privosegtor also has potential to be developed for additional indications in other neuro-ophthalmic and neuro-axonal diseases. Licaminlimab is a novel, topical anti-TNF\u03b1 in a registrational trial, and is being developed with a genotype-based approach for treating patients with dry eye disease (DED). Headquartered in Switzerland with operations in the U.S., Iceland and Switzerland, Oculis is led by an experienced management team with a successful track record and supported by leading international healthcare investors.<br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<br \/>For more information, please visit: www.oculis.com<\/p>\n<p align=\"justify\">\n        <b>Oculis Contact<\/b><br \/>\n        <br \/>Ms. Sylvia Cheung, CFO<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qPdHAuIfRiEdtDhHgiGW11e33hjDm1SaLBRFtI6QBrcV5YcWGJSEPEwNAz0xdVO26vNww9OyjreF4ML4kVjPqu7EJ75vQhXS63KjXmwDyUhDwxjLRQP0AP6MjLO1oQ0-\" rel=\"nofollow\" target=\"_blank\">sylvia.cheung@oculis.com<\/a><\/p>\n<p>\n        <b>Investor Relations <\/b><br \/>\n        <br \/>LifeSci Advisors<br \/>Corey Davis, Ph.D.<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=irKiWnsHgGOK0TtlW2MX9Wl7h-1xuJbsmZtNXY4rwZHFbVRKtPtfLI74-GOh4qFjiT2jWO6wR0ix94A-mJw-ytgd1SI_Wr6BwrJEv1d9m0Kx2VaCJ_UTQ5oqdVEmNfVM\" rel=\"nofollow\" target=\"_blank\"><u>cdavis@lifesciadvisors.com<\/u><\/a><\/p>\n<p>\n        <b>Media Relations<\/b><br \/>\n        <br \/>ICR Healthcare<br \/>Amber Fennell <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fXNcfCCR7C5y0-BM5qg8lT-L8q_VN1r4pCkKwZSGypfirwDX7lbaG2C8fjtEO20dCSQr3cEw71a2LuVOvhS8L0J_lUzE_itEsKv1ttq0W7bo9xz69nagEwtppnD15eaSjeoT_PtKGb_CVE9RkQQm3qceD62rzZINpbkc843NpCHXAIbSQWo0TTm9Tr2Q14frWQHe1hcD4nCpX78my9-e8FhJRDIK2w6toguL8namk51EYdybB0w9QHmH6Md5A3D7EQsrE4ysH8fBsoBUh-zCO7lApVg274eTMbMoe05Uk4Zbk4VRL6IRtpWjJgG82wMT\" rel=\"nofollow\" target=\"_blank\">oculis@icrhealthcare.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTI3NTYyNCM0MDI1MjA2NzYjMjE4OTAyMw==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/YmQzNWRjZDQtYjJjMy00YmYyLWI1MDEtOTZmNmE2ZGY4ZThhLTEyMDA1NzYtMjAyNi0wOS0zMC1lbg==\/tiny\/Oculis-Holding-AG.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Oculis Announces Resignation of Lionel Carnot from Board of Directors ZUG, Switzerland, September 30, 2026 &#8212; Oculis Holding AG (Nasdaq: OCS \/ XICE: OCS) (\u201cOculis\u201d or the \u201cCompany\u201d), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in neuro-ophthalmology and ophthalmology, today announces that director Lionel Carnot will be resigning from the Board of Directors, effective today, after nearly a decade of dedicated service since 2017. Anthony Rosenberg, Chair of the Board, remarked: \u201cOn behalf of the Board and the entire Oculis team, we wish to extend our sincere gratitude to Lionel for his invaluable service, leadership and guidance over nearly a decade, covering a transformative period for Oculis, where it evolved from a private &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-announces-resignation-of-lionel-carnot-from-board-of-directors\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Oculis Announces Resignation of Lionel Carnot from Board of Directors&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1007285","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Oculis Announces Resignation of Lionel Carnot from Board of Directors - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-announces-resignation-of-lionel-carnot-from-board-of-directors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Oculis Announces Resignation of Lionel Carnot from Board of Directors - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Oculis Announces Resignation of Lionel Carnot from Board of Directors ZUG, Switzerland, September 30, 2026 &#8212; Oculis Holding AG (Nasdaq: OCS \/ XICE: OCS) (\u201cOculis\u201d or the \u201cCompany\u201d), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in neuro-ophthalmology and ophthalmology, today announces that director Lionel Carnot will be resigning from the Board of Directors, effective today, after nearly a decade of dedicated service since 2017. Anthony Rosenberg, Chair of the Board, remarked: \u201cOn behalf of the Board and the entire Oculis team, we wish to extend our sincere gratitude to Lionel for his invaluable service, leadership and guidance over nearly a decade, covering a transformative period for Oculis, where it evolved from a private &hellip; Continue reading &quot;Oculis Announces Resignation of Lionel Carnot from Board of Directors&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-announces-resignation-of-lionel-carnot-from-board-of-directors\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-30T21:36:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTI3NTYyNCM0MDI1MjA2NzYjMjE4OTAyMw==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-announces-resignation-of-lionel-carnot-from-board-of-directors\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-announces-resignation-of-lionel-carnot-from-board-of-directors\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Oculis Announces Resignation of Lionel Carnot from Board of Directors\",\"datePublished\":\"2026-09-30T21:36:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-announces-resignation-of-lionel-carnot-from-board-of-directors\\\/\"},\"wordCount\":532,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-announces-resignation-of-lionel-carnot-from-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTI3NTYyNCM0MDI1MjA2NzYjMjE4OTAyMw==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-announces-resignation-of-lionel-carnot-from-board-of-directors\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-announces-resignation-of-lionel-carnot-from-board-of-directors\\\/\",\"name\":\"Oculis Announces Resignation of Lionel Carnot from Board of Directors - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-announces-resignation-of-lionel-carnot-from-board-of-directors\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-announces-resignation-of-lionel-carnot-from-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTI3NTYyNCM0MDI1MjA2NzYjMjE4OTAyMw==\",\"datePublished\":\"2026-09-30T21:36:11+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-announces-resignation-of-lionel-carnot-from-board-of-directors\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-announces-resignation-of-lionel-carnot-from-board-of-directors\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-announces-resignation-of-lionel-carnot-from-board-of-directors\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTI3NTYyNCM0MDI1MjA2NzYjMjE4OTAyMw==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTI3NTYyNCM0MDI1MjA2NzYjMjE4OTAyMw==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-announces-resignation-of-lionel-carnot-from-board-of-directors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Oculis Announces Resignation of Lionel Carnot from Board of Directors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Oculis Announces Resignation of Lionel Carnot from Board of Directors - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-announces-resignation-of-lionel-carnot-from-board-of-directors\/","og_locale":"en_US","og_type":"article","og_title":"Oculis Announces Resignation of Lionel Carnot from Board of Directors - Market Newsdesk","og_description":"Oculis Announces Resignation of Lionel Carnot from Board of Directors ZUG, Switzerland, September 30, 2026 &#8212; Oculis Holding AG (Nasdaq: OCS \/ XICE: OCS) (\u201cOculis\u201d or the \u201cCompany\u201d), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in neuro-ophthalmology and ophthalmology, today announces that director Lionel Carnot will be resigning from the Board of Directors, effective today, after nearly a decade of dedicated service since 2017. Anthony Rosenberg, Chair of the Board, remarked: \u201cOn behalf of the Board and the entire Oculis team, we wish to extend our sincere gratitude to Lionel for his invaluable service, leadership and guidance over nearly a decade, covering a transformative period for Oculis, where it evolved from a private &hellip; Continue reading \"Oculis Announces Resignation of Lionel Carnot from Board of Directors\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-announces-resignation-of-lionel-carnot-from-board-of-directors\/","og_site_name":"Market Newsdesk","article_published_time":"2026-09-30T21:36:11+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTI3NTYyNCM0MDI1MjA2NzYjMjE4OTAyMw==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-announces-resignation-of-lionel-carnot-from-board-of-directors\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-announces-resignation-of-lionel-carnot-from-board-of-directors\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Oculis Announces Resignation of Lionel Carnot from Board of Directors","datePublished":"2026-09-30T21:36:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-announces-resignation-of-lionel-carnot-from-board-of-directors\/"},"wordCount":532,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-announces-resignation-of-lionel-carnot-from-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTI3NTYyNCM0MDI1MjA2NzYjMjE4OTAyMw==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-announces-resignation-of-lionel-carnot-from-board-of-directors\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-announces-resignation-of-lionel-carnot-from-board-of-directors\/","name":"Oculis Announces Resignation of Lionel Carnot from Board of Directors - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-announces-resignation-of-lionel-carnot-from-board-of-directors\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-announces-resignation-of-lionel-carnot-from-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTI3NTYyNCM0MDI1MjA2NzYjMjE4OTAyMw==","datePublished":"2026-09-30T21:36:11+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-announces-resignation-of-lionel-carnot-from-board-of-directors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/oculis-announces-resignation-of-lionel-carnot-from-board-of-directors\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-announces-resignation-of-lionel-carnot-from-board-of-directors\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTI3NTYyNCM0MDI1MjA2NzYjMjE4OTAyMw==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTI3NTYyNCM0MDI1MjA2NzYjMjE4OTAyMw=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-announces-resignation-of-lionel-carnot-from-board-of-directors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Oculis Announces Resignation of Lionel Carnot from Board of Directors"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1007285","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1007285"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1007285\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1007285"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1007285"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1007285"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}